Dennis Charles Sgroi, M.D.
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Dennis Sgroi's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Dennis Sgroi has written about over time.
Antigens, Differentiation, B-LymphocyteLectinsCarcinoma, Ductal, BreastLasersCarcinoma, Intraductal, NoninfiltratingMicrodissectionGene Expression ProfilingGene Expression Regulation, NeoplasticReceptors, InterleukinBreast NeoplasmsHomeodomain ProteinsBreastTamoxifenReceptor, ErbB-2Receptors, EstrogenAntineoplastic Agents, HormonalNitrilesNeoplasm Recurrence, LocalReceptors, Progesterone
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Antigens, Differentiation, B-Lymphocyte | 9 | 1991 | 1999 | April 1994 |
| Lectins | 10 | 1991 | 1999 | September 1994 |
| Carcinoma, Ductal, Breast | 16 | 1994 | 2018 | April 2004 |
| Lasers | 13 | 1999 | 2010 | June 2005 |
| Carcinoma, Intraductal, Noninfiltrating | 7 | 2001 | 2013 | August 2007 |
| Microdissection | 10 | 2003 | 2011 | September 2007 |
| Gene Expression Profiling | 27 | 2001 | 2017 | March 2008 |
| Gene Expression Regulation, Neoplastic | 38 | 2001 | 2018 | March 2010 |
| Receptors, Interleukin | 9 | 2006 | 2016 | March 2010 |
| Breast Neoplasms | 97 | 1994 | 2024 | April 2010 |
| Homeodomain Proteins | 15 | 2004 | 2022 | March 2011 |
| Breast | 12 | 1997 | 2023 | March 2011 |
| Tamoxifen | 25 | 2004 | 2022 | December 2011 |
| Receptor, ErbB-2 | 14 | 2005 | 2022 | July 2012 |
| Receptors, Estrogen | 23 | 2004 | 2024 | October 2012 |
| Antineoplastic Agents, Hormonal | 20 | 2004 | 2022 | August 2013 |
| Nitriles | 6 | 2005 | 2024 | August 2014 |
| Neoplasm Recurrence, Local | 15 | 2006 | 2022 | February 2015 |
| Receptors, Progesterone | 9 | 2006 | 2024 | September 2015 |